Screening for cancer

Advice for high-value care from the American college of physicians

High Value Care Task Force of the American College of Physicians

Research output: Contribution to journalReview article

82 Citations (Scopus)

Abstract

Background: Cancer screening is one approach to reducing cancer-related morbidity and mortality rates. Screening strategies vary in intensity. Higher-intensity strategies are not necessarily higher value. High-value strategies provide a degree of benefits that clearly justifies the harms and costs incurred; low-value screening provides limited or no benefits to justify the harms and costs. When cancer screening leads to benefits, an optimal intensity of screening maximizes value. Some aspects of screening practices, especially overuse and underuse, are low value. Methods: Screening strategies for asymptomatic, average-risk adults for 5 common types of cancer were evaluated by reviewing clinical guidelines and evidence syntheses from the American College of Physicians (ACP), U.S. Preventive Services Task Force, American Academy of Family Physicians, American Cancer Society, American Congress of Obstetricians and Gynecologists, American Gastroenterological Association, and American Urological Association. "High value" was defined as the lowest screening intensity threshold at which organizations agree about screening recommendations for each type of cancer and "low value" as agreement about not recommending overly intensive screening strategies. This information is supplemented with additional findings from randomized, controlled trials; modeling studies; and studies of costs or resource use, including information found in the National Cancer Institute's Physician Data Query and UpToDate. The ACP provides high-value care screening advice for 5 common types of cancer; the specifics are outlined in this article. The ACP strongly encourages clinicians to adopt a cancer screening strategy that focuses on reaching all eligible persons with these high-value screening options while reducing overly intensive, low-value screening.

Original languageEnglish (US)
Pages (from-to)718-725
Number of pages8
JournalAnnals of internal medicine
Volume162
Issue number10
DOIs
StatePublished - Jan 1 2015

Fingerprint

Early Detection of Cancer
Physicians
Costs and Cost Analysis
Neoplasms
National Cancer Institute (U.S.)
Family Physicians
Advisory Committees
Randomized Controlled Trials
Organizations
Guidelines
Morbidity
Mortality

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Screening for cancer : Advice for high-value care from the American college of physicians. / High Value Care Task Force of the American College of Physicians.

In: Annals of internal medicine, Vol. 162, No. 10, 01.01.2015, p. 718-725.

Research output: Contribution to journalReview article

High Value Care Task Force of the American College of Physicians 2015, 'Screening for cancer: Advice for high-value care from the American college of physicians', Annals of internal medicine, vol. 162, no. 10, pp. 718-725. https://doi.org/10.7326/M14-2326
High Value Care Task Force of the American College of Physicians. Screening for cancer: Advice for high-value care from the American college of physicians. Annals of internal medicine. 2015 Jan 1;162(10):718-725. https://doi.org/10.7326/M14-2326
High Value Care Task Force of the American College of Physicians. / Screening for cancer : Advice for high-value care from the American college of physicians. In: Annals of internal medicine. 2015 ; Vol. 162, No. 10. pp. 718-725.
@article{b68b765796874e948cd41da0d5a23932,
title = "Screening for cancer: Advice for high-value care from the American college of physicians",
abstract = "Background: Cancer screening is one approach to reducing cancer-related morbidity and mortality rates. Screening strategies vary in intensity. Higher-intensity strategies are not necessarily higher value. High-value strategies provide a degree of benefits that clearly justifies the harms and costs incurred; low-value screening provides limited or no benefits to justify the harms and costs. When cancer screening leads to benefits, an optimal intensity of screening maximizes value. Some aspects of screening practices, especially overuse and underuse, are low value. Methods: Screening strategies for asymptomatic, average-risk adults for 5 common types of cancer were evaluated by reviewing clinical guidelines and evidence syntheses from the American College of Physicians (ACP), U.S. Preventive Services Task Force, American Academy of Family Physicians, American Cancer Society, American Congress of Obstetricians and Gynecologists, American Gastroenterological Association, and American Urological Association. {"}High value{"} was defined as the lowest screening intensity threshold at which organizations agree about screening recommendations for each type of cancer and {"}low value{"} as agreement about not recommending overly intensive screening strategies. This information is supplemented with additional findings from randomized, controlled trials; modeling studies; and studies of costs or resource use, including information found in the National Cancer Institute's Physician Data Query and UpToDate. The ACP provides high-value care screening advice for 5 common types of cancer; the specifics are outlined in this article. The ACP strongly encourages clinicians to adopt a cancer screening strategy that focuses on reaching all eligible persons with these high-value screening options while reducing overly intensive, low-value screening.",
author = "{High Value Care Task Force of the American College of Physicians} and Wilt, {Timothy J.} and Harris, {Russell P.} and Amir Qaseem and John Biebelhausen and Sanjay Desai and Lawrence Feinberg and Horwitch, {Carrie A.} and Humphrey, {Linda L.} and McLean, {Robert M.} and Mir, {Tanveer P.} and Moyer, {Darilyn V.} and Skeff, {Kelley M.} and Tape, {Thomas Gerald} and Jeffrey Wiese",
year = "2015",
month = "1",
day = "1",
doi = "10.7326/M14-2326",
language = "English (US)",
volume = "162",
pages = "718--725",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "10",

}

TY - JOUR

T1 - Screening for cancer

T2 - Advice for high-value care from the American college of physicians

AU - High Value Care Task Force of the American College of Physicians

AU - Wilt, Timothy J.

AU - Harris, Russell P.

AU - Qaseem, Amir

AU - Biebelhausen, John

AU - Desai, Sanjay

AU - Feinberg, Lawrence

AU - Horwitch, Carrie A.

AU - Humphrey, Linda L.

AU - McLean, Robert M.

AU - Mir, Tanveer P.

AU - Moyer, Darilyn V.

AU - Skeff, Kelley M.

AU - Tape, Thomas Gerald

AU - Wiese, Jeffrey

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background: Cancer screening is one approach to reducing cancer-related morbidity and mortality rates. Screening strategies vary in intensity. Higher-intensity strategies are not necessarily higher value. High-value strategies provide a degree of benefits that clearly justifies the harms and costs incurred; low-value screening provides limited or no benefits to justify the harms and costs. When cancer screening leads to benefits, an optimal intensity of screening maximizes value. Some aspects of screening practices, especially overuse and underuse, are low value. Methods: Screening strategies for asymptomatic, average-risk adults for 5 common types of cancer were evaluated by reviewing clinical guidelines and evidence syntheses from the American College of Physicians (ACP), U.S. Preventive Services Task Force, American Academy of Family Physicians, American Cancer Society, American Congress of Obstetricians and Gynecologists, American Gastroenterological Association, and American Urological Association. "High value" was defined as the lowest screening intensity threshold at which organizations agree about screening recommendations for each type of cancer and "low value" as agreement about not recommending overly intensive screening strategies. This information is supplemented with additional findings from randomized, controlled trials; modeling studies; and studies of costs or resource use, including information found in the National Cancer Institute's Physician Data Query and UpToDate. The ACP provides high-value care screening advice for 5 common types of cancer; the specifics are outlined in this article. The ACP strongly encourages clinicians to adopt a cancer screening strategy that focuses on reaching all eligible persons with these high-value screening options while reducing overly intensive, low-value screening.

AB - Background: Cancer screening is one approach to reducing cancer-related morbidity and mortality rates. Screening strategies vary in intensity. Higher-intensity strategies are not necessarily higher value. High-value strategies provide a degree of benefits that clearly justifies the harms and costs incurred; low-value screening provides limited or no benefits to justify the harms and costs. When cancer screening leads to benefits, an optimal intensity of screening maximizes value. Some aspects of screening practices, especially overuse and underuse, are low value. Methods: Screening strategies for asymptomatic, average-risk adults for 5 common types of cancer were evaluated by reviewing clinical guidelines and evidence syntheses from the American College of Physicians (ACP), U.S. Preventive Services Task Force, American Academy of Family Physicians, American Cancer Society, American Congress of Obstetricians and Gynecologists, American Gastroenterological Association, and American Urological Association. "High value" was defined as the lowest screening intensity threshold at which organizations agree about screening recommendations for each type of cancer and "low value" as agreement about not recommending overly intensive screening strategies. This information is supplemented with additional findings from randomized, controlled trials; modeling studies; and studies of costs or resource use, including information found in the National Cancer Institute's Physician Data Query and UpToDate. The ACP provides high-value care screening advice for 5 common types of cancer; the specifics are outlined in this article. The ACP strongly encourages clinicians to adopt a cancer screening strategy that focuses on reaching all eligible persons with these high-value screening options while reducing overly intensive, low-value screening.

UR - http://www.scopus.com/inward/record.url?scp=84937511461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937511461&partnerID=8YFLogxK

U2 - 10.7326/M14-2326

DO - 10.7326/M14-2326

M3 - Review article

VL - 162

SP - 718

EP - 725

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 10

ER -